- Home
- CVM vs TRIB Comparison
CVM vs TRIB Comparison
Compare CVM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- TRIB
- Stock Information
- Founded
- CVM 1983
- TRIB 1992
- Country
- CVM United States
- TRIB Ireland
- Employees
- CVM N/A
- TRIB N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CVM Health Care
- TRIB Health Care
- Exchange
- CVM Nasdaq
- TRIB Nasdaq
- Market Cap
- CVM 11.8M
- TRIB 14.0M
- IPO Year
- CVM 1987
- TRIB N/A
- Fundamental
- Price
- CVM $3.46
- TRIB $0.79
- Analyst Decision
- CVM
- TRIB
- Analyst Count
- CVM 0
- TRIB 0
- Target Price
- CVM N/A
- TRIB N/A
- AVG Volume (30 Days)
- CVM 1.6M
- TRIB 2.4M
- Earning Date
- CVM 08-14-2025
- TRIB 08-13-2025
- Dividend Yield
- CVM N/A
- TRIB N/A
- EPS Growth
- CVM N/A
- TRIB N/A
- EPS
- CVM N/A
- TRIB N/A
- Revenue
- CVM N/A
- TRIB $61,555,000.00
- Revenue This Year
- CVM N/A
- TRIB $13.51
- Revenue Next Year
- CVM N/A
- TRIB $13.14
- P/E Ratio
- CVM N/A
- TRIB N/A
- Revenue Growth
- CVM N/A
- TRIB 8.31
- 52 Week Low
- CVM $1.98
- TRIB $0.48
- 52 Week High
- CVM $66.60
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- CVM 57.66
- TRIB 61.96
- Support Level
- CVM $2.24
- TRIB $0.72
- Resistance Level
- CVM $2.71
- TRIB $0.79
- Average True Range (ATR)
- CVM 0.51
- TRIB 0.09
- MACD
- CVM 0.25
- TRIB 0.02
- Stochastic Oscillator
- CVM 25.61
- TRIB 75.00
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.